ALGS | VRTX | REGN | ALNY | SGEN | ARGX | |
---|---|---|---|---|---|---|
Company Name | Aligos Therapeutics, Inc. | Vertex Pharmaceuticals Incorporated | Regeneron Pharmaceuticals, Inc. | Alnylam Pharmaceuticals, Inc. | Seagen Inc. | argenx SE |
Sector | Healthcare | Healthcare | Healthcare | Healthcare | Healthcare | Healthcare |
Industry | Biotechnology | Biotechnology | Biotechnology | Biotechnology | Biotechnology | Biotechnology |
Market Cap | $47.94M | $117.98B | $57.12B | $43.28B | $43.15B | $33.34B |
Employees | 0.07K | 6.10K | 15.16K | 2.23K | 3.26K | 1.60K |
CEO | Lawrence M. Blatt MBA, | Reshma Kewalramani FASN, | Leonard S. Schleifer | Yvonne L. Greenstreet | David R. Epstein | Timothy Van Hauwermeiren EMBA, |